ERCC1 and neuropathy: A Japanese study of colorectal cancer patients treated with oxaliplatin‐based chemotherapy estimated the pharmacogenetic correlation between neuropathy and polymorphisms of the excision repair cross‐complementation Group 1 (ERCC1) and glutathione‐S‐transferases pi 1 (GSTP1) genes.